Page last updated: 2024-09-03

dibutyryl cyclic-3',5'-cytidine monophosphate and Pheochromocytoma

dibutyryl cyclic-3',5'-cytidine monophosphate has been researched along with Pheochromocytoma in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Cline, MJ; Horvai, AE; Kalman, D; O'Lague, PH; Wong, B1
Gohda, E; Yamamoto, I; Yanagida, M1

Other Studies

2 other study(ies) available for dibutyryl cyclic-3',5'-cytidine monophosphate and Pheochromocytoma

ArticleYear
Nerve growth factor acts through cAMP-dependent protein kinase to increase the number of sodium channels in PC12 cells.
    Neuron, 1990, Volume: 4, Issue:3

    Topics: 1-Methyl-3-isobutylxanthine; Adrenal Gland Neoplasms; Animals; Bucladesine; Cell Differentiation; Cell Line; Colforsin; Cyclic CMP; Dibutyryl Cyclic GMP; Dimethyl Sulfoxide; Electric Conductivity; Electrophysiology; Gene Expression; Genes, ras; Kinetics; Nerve Growth Factors; Pheochromocytoma; Protein Kinases; Rats; Sodium Channels; Tetrodotoxin

1990
Dibutyrylcytidine 3',5'-cyclic monophosphate stimulates neurite outgrowth in rat pheochromocytoma PC12.
    Neuroscience letters, 1990, Jul-13, Volume: 114, Issue:3

    Topics: Adrenal Gland Neoplasms; Animals; Axons; Cyclic CMP; Cytosine Nucleotides; Nerve Growth Factors; Pheochromocytoma; Rats

1990